Stock listing

APUS Stock Price, News, Filings & Events — Apimeds Pharmaceuticals Us, Inc.

Selected listing: APUS · AMEX · USD · US

This page tracks Apimeds Pharmaceuticals Us, Inc.'s APUS:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following APUS:AMEX. APUS:AMEX is the stock-level entry point for investors researching Apimeds Pharmaceuticals Us, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Apimeds Pharmaceuticals Us, Inc. (ticker: APUS) is a public company operating in the American market. With a market capitalization of approximately $98.6 million, the company focuses on developing pharmaceutical products. Investors can find relevant information about its operations and performance on its dedicated public company page.